Modulation of cell-mediated immunity prolongs adenovirus-mediated transgene expression in sciatic nerve

Human Gene Therapy

Volumn 10, Issue 5, 1999, Pages 787-800

  Jani, Agnes ^a   Menichella, Daniela ^a,b   Jiang, Huiyuan ^a   Chbihi, Taibi ^a   Acsadi, Gyula ^a   Shy, Michael E ^a   Kamholz, John ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BACTERIAL GENE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; GENE TRANSFER; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LACTOSE OPERON; MOUSE; NERVE FIBER; NERVE SHEATH; NONHUMAN; PERIPHERAL NEUROPATHY; RAT; SCHWANN CELL; SCIATIC NERVE; SCID MOUSE; TISSUE INJURY; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; AGE FACTORS; ANIMALS; AZO COMPOUNDS; BETA-GALACTOSIDASE; BLOTTING, SOUTHERN; CHEMILUMINESCENT MEASUREMENTS; COLORING AGENTS; DNA PRIMERS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LAC OPERON; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS; SCIATIC NERVE; TACROLIMUS; TIME FACTORS;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); DNA VIRUSES; ESCHERICHIA COLI; WALLERIA;

EID: 0033586333     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018544     Document Type: Article

References (50)

1. ACSADI, G., JANI, A., HUARD, J., BLASCHUK, K., MASSIE, B., HOLLAND, P., LOCHMULLER, H., and KARPATI, G. (1994a). Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1, 338-340.
2. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., and KARPATI, G. (1994b). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
3. ACSADI, G., MASSIE, B., and JANI, A. (1995). Adenovirus-mediated gene transfer into striated muscles. J. Mol. Med. 73, 165-180.
4. ACSADI, G., LOCHMULLER, H., JANI, A., HUARD, J., MASSIE, B., PRESCOTT, S., SIMONEAU, M., PETROF, B., and KARPATI, G. (1996). Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
5. ACSADI, G., O'HAGAN, D., LOCHMULLER, H., PRESCOTT, S., LAROCHELLE, N., NALBANTOGLU, J., JANI, A., and KARPATI, G. (1998). Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells. J. Mol. Med. 76, 442-450.
6. ARMENTANO, D., ZABNER, J., SACKS, C., SOOCKDEO, C.C., SMITH, M.P., ST. GEORGE, J.A., WADSWORTH, S.C., SMITH, A.E., and GREGORY, R.J. (1997). Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71, 2408-2416.
7. BOSMA, G.C., CUSTER, R.P., and BOSMA, M.J. (1983). A severe combined immunodeficiency mutation in the mouse. Nature (London) 301, 527-530.
8. BOSMA, M.J., and CARROLL, A.M. (1991). The SCID mouse mutant: Definition, characterization and potential uses. Annu. Rev. Immunol. 9, 323-350.
9. BOUCHER, R.C., and KNOWLES, M.R. (1994). Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase 1 trial in the nasal cavity. Hum. Gene Ther. 5, 615-639.
10. BROCKES, J.F., FIELDS, K.L., and RAFF, M. (1979). Studies on cultured rat Schwann cells. 1. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165, 105-118.
11. CHEN, H.H., MACK, L.M., KELLY, R., ONTELL, M., KOCHANEK, S., and CLEMENS, P. (1997). Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. U.S.A. 94, 645-1650.
12. CHROBOCZEK, J., BIEBER, F., and JACROT, B. (1992). The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186, 280-285.
13. CLEMENS, P.R., KOCHANEK, S., SUNADA, Y., CHAN, S., CHEN, H.-H., CAMPBELL, K.P., and CASKEY, C.T. (1996). In vivo muscle gene transfer of full length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3, 965-972.
14. DAI, Y., SCHWARTZ, E., GU, D., ZHANG, W., SARVETNICK, N., and VERMA, I. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. U.S.A. 92, 1401-1405.
15. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-234.
16. DE WAEGH, S., and BRADY, S.T. (1990). Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: The Trembler as an in vivo model for Schwann cell-axon interactions. J. Neurosci. 10, 1855-1865.
17. DYCK, P.J., WINDEBANK, A.J., LOW, P.A., and BAUMAN, W.J. (1980). Blood-nerve barrier in rat and cellular mechanisms of lead-induced segmental demyelination. J. Neuropathol. Exp. Neurol. 38, 700.
18. DYCK, P.J., GIANNINI, C., and LAIS, A. (1993). Pathologic alterations of nerves. In Peripheral Neuropathy. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, and J.P. Poduslo, eds. (W.B. Saunders, Philadelphia, PA) pp. 514-517.
19. FISHER, K.J., CHOI, H., BURDA, J., CHEN, S.-J., and WILSON, J.M. (1996). Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217, 11-22.
20. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Gene Transfer and Expression Protocols. E.J. Murray, ed. (Humana Press, Clifton, NJ) pp. 109-114.
21. HARDY, S., KITAMURA, M., HARRIS-STANSIL, T., DAI, Y., and PHIPPS, M.L. (1997). Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71, 1842-1849.
22. HOOGENDIJK, J.E., DE VISSER, M., BOLHUIS, M., HART, P.A., ONGERBOER, A.A.M., and DE VISSER, B.W. (1994). Hereditary motor and sensory neuropathy type I: Clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 17, 85-90.
23. JANI, A., LOCHMULLER, H., ACSADI, G., SIMONEAU, M., HUARD, J., GARNIER, A., KARPATI, G., and MASSIE, B. (1997). Generation, validation and large scale production of adenoviral recombinants with large size inserts such as the 6.3 kb human dystrophin cDNA. J. Virol. Methods 64, 111-124.
24. JOOS, K., YANG, Y., and WILSON, J.M. (1996). Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7, 1555-1566.
25. KLEITMAN, N., WOOD, P.M., and BUNGE, R. (1991). Tissue culture methods for the study of myelination. In Culturing Nerve Cells. G. Banker and K. Goslin, eds. (MIT Press, Cambridge, MA) pp. 337-377.
26. KUMAR-SINGH, R., and CHAMBERLAIN, J.S. (1996). Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5, 913-921.
27. LIEBER, A., HE, C.-Y., KIRILLOVA, I., and KAY, M.A. (1996). Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70, 8944-8960.
28. LIU, J., FARMER, J.D., LANE, W.S., FRIEDMAN, I., WEISSMAN, I., and SCHREIBER, S.L. (1991). Calcineurin is a common target of cyclophylin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
29. LOCHMULLER, H., PETROF, B.J., PARI, G., LAROCHELLE, N., DODELET, V., WANG, Q., ALLEN, C., PRESCOTT, S., MASSIE, B., NALBANTOGLU, J., and KARPATI, G. (1996). Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3, 706-716.
30. MATLOUBIAN, M., CONCEPCION, R.J., and AHMED, R. (1994). CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063.
31. McDIARMID, S.V., BUSUTTIL, R.W., ASCHER, N.L., BURDICK, J., D'ALESSANDRO, A.M., ESQUIVEL, C., KALAYOGLU, M., KLEIN, A.S., MARSH, J.W., and MILLER, C.M. (1995). FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation 59, 530-536.
32. MCKHANN, G.M., GRIFFIN, J.W., CORNBLATH, D.R., QUASKEY, S.A., and MELLITS, E.D. (1988). Role of therapeutic plasmapheresis in the acute Guillain-Barré syndrome. J. Neuroimmunol. 20, 297-300.
33. MITANI, K., GRAHAM, F.L., CASKEY, C.T., and KOCHANEK, S. (1995). Rescue, propagation and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. U.S.A. 92, 3854-3858.
34. MURASE, N., KIM, D.G., TODO, S., CRAMER, D.V., FUNG, J.J., and STARZL, T.E. (1990). Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation 50, 186-189.
35. PETROF, B.J., LOCHMULLER, H., MASSIE, B., YANG, L., MACMILLAN, C., ZHAO, J.F., NALBANTOGLU, J., and KARPATI, G. (1996). Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency. Hum. Gene Ther. 7, 1813-1826.
36. PODACK, E.R., HENGARTNER, H., and LICHTENHELD, M.G. (1991). A central role of perform in cytolysis. Annu. Rev. Immunol. 9, 129-152.
37. PODUSLO, J.F. (1993). Albumin and the blood-nerve barrier. In Peripheral Neuropathy. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, and J.P. Poduslo, eds. (W.B. Saunders, Philadelphia, PA) pp. 446-452.
38. PORTER, S., CLARK, M.B., GLASER, L., and BUNGE, R.P. (1986). Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability. J. Neurosci. 6, 3070-3078.
39. RECHTHAND, E., and RAPOPORT, S.I. (1987). Regulation of the microenvironment of peripheral nerve: Role of the blood-nerve barrier. Prog. Neurobiol. 28, 303-343.
40. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
41. SCHIEDNER, G., MORRAL, N., PARKS, R.J., WU, Y., KOOPMANS, S.C., LANGSTON, C., GRAHAM, F.L., BEAUDET, A.L., and KOCHANEK, S. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genet. 18, 180-183.
42. SHY, M.E., TANI, M., SHI, Y.J., WHYATT, S.A., CHBIHI, T., SCHERER, S.S., and KAMHOLZ, J. (1995). An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve. Ann. Neurol. 38, 429-436.
43. SORENSEN, J., HAASE, G., KRARUP, C., GILGENKRANTZ, H., KAHN, A., and SCHMALBRUCH, R. (1998). Gene transfer to Schwann cells after peripheral nerve injury: A delivery system for therapeutic agents. Ann. Neurol. 43, 205-211.
44. SPENCER, P.S., WEINBERG, H.J., RAINE, C.S., and PRINEAS, J.W. (1975). The perineurial window - a new model of focal demyelination and remyelination. Brain Res. 96, 323-329.
45. VAN GINKEL, F.W., LIU, C., SIMECKA, J.W., DONG, J.-Y., GREENWAY, T., FRIZZELL, R.A., KIYONO, H., McGHEE, J.E., and PASCUAL, D.W. (1995). Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6, 895-903.
46. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-437.
47. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
48. YANG, Y., HAECKER, S.E., SU, Q., and WILSON, J.M. (1996a). Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5, 1703-1712.
49. YANG, Y., SU, Q., and WILSON, J.M. (1996b). Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70, 7209-7212.
50. ZIJLSTRA, M., BIX, M., SIMISTER, N.E., LORING, J.M., RAULET, D.H., and JAENISCH, R. (1990). β2-Microglobulin deficient mice lack CD4-CD8+ cytolytic T cells. Nature (London) 344, 742-746.